Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $249.1100 (0.61%) ($246.0100 - $255.3800) on Tue. Aug. 14, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.16% (three month average) | RSI | 62 | Latest Price | $249.1100(0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 4.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.08% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-9%) GDXJ(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.08% (StdDev 2.16%) | Hourly BBV | 0 () | Intraday Trend | 0.5% | | | |
|
5 Day Moving Average | $243.54(2.29%) | 10 Day Moving Average | $236.84(5.18%) | 20 Day Moving Average | $231.98(7.38%) | To recent high | 0% | To recent low | 37.4% | Market Cap | $4.003b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |